Condition
    Preliminary
    Effectiveness 6/5

    Quercetin for Allergic Rhinitis

    Quercetin stabilizes mast cells — preventing histamine release rather than blocking it after the fact. Human trials for allergic rhinitis are small but positive, especially with better-absorbed phytosome forms. Best as a preventive layer alongside (not instead of) antihistamines.

    Overview

    Quercetin stabilizes mast cells — preventing histamine release rather than blocking it after the fact. Human trials for allergic rhinitis are small but positive, especially with better-absorbed phytosome forms. Best as a preventive layer alongside (not instead of) antihistamines.

    Verdict

    Mixed evidence

    Promising preventive layer for seasonal allergies — start before the season hits.

    How It Works

    Inhibits mast cell degranulation, reducing histamine and leukotriene release at the source; also dampens Th2-driven allergic inflammation and eosinophil activity in nasal mucosa.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500 mg quercetin phytosome twice daily, started 2-4 weeks before allergy season
    Expected timeframe
    2-4 weeks of consistent dosing before benefit is apparent; not an acute rescue remedy.

    Protocol

    dose
    250-500 mg twice daily
    form
    Quercetin phytosome (preferred) or plain quercetin with fat/bromelain
    timing
    With meals; begin 2-4 weeks before allergy season
    duration
    Throughout allergy season
    monitoring
    Track daily symptom scores and antihistamine use

    Evidence

    What the studies say

    Small RCTs of quercetin (including phytosome forms) show reduced sneezing, nasal discharge, and eye symptoms in seasonal allergic rhinitis. Mechanistic evidence is strong; trial sizes remain small. Quercetin is slower than antihistamines and works best started weeks before exposure — it raises the threshold rather than rescuing acute symptoms.

    Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial

    Score: 6/10
    2009
    rct
    n=20

    Kawai M, Hirano T, Arimitsu J +2 more

    total ocular score and ocular itching score for the EMIQ group were significantly lower (p < 0.05) than for the placebo group

    View source

    Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis

    Score: 6/10
    2009
    rct
    n=24

    Hirano T, Kawai M, Arimitsu J +2 more

    ocular symptom + medication score for the EMIQ group was significantly lower (p < 0.05) than that of the placebo group

    View source

    Safety

    Caveats

    Form matters enormously — plain quercetin is poorly absorbed. Choose phytosome complexes. Does not replace antihistamines for moderate-to-severe symptoms; think of it as lowering the baseline. Human evidence rests on two small Japanese cedar pollinosis trials (n=20 and n=24) of enzymatically modified isoquercitrin, which improved ocular symptoms but not nasal symptoms; no large allergic rhinitis RCT exists.

    Less likely to help if

    If a full season at adequate phytosome dosing changes nothing, quercetin is unlikely to help your specific allergy profile. Nasal steroid sprays remain the most effective single OTC-adjacent option.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.